Abstract: The subject invention provides a rapid sequence intubation tray that enables fast and accurate medication dosing of patients under emergency conditions. By “automating” medication dosing, the subject invention reduces delays in medication administration and reduces the risk of medication errors.
Abstract: Amooranin (AMR) has been found to cause tumor cell death through G2/M cell cycle arrest, caspase activation, and apoptosis. Furthermore, it has been demonstrated that AMR is a substrate for P-glycoprotein. Based on these activities, AMR compounds, including AMR analogs, can be used in the treatment of a number of diseases in which aberrant cellular proliferation occurs such as drug-sensitive and drug-resistant cancers, autoimmune disorders, and inflammatory diseases.